News
Layoffs have become a common business practice, but research shows long-term performance actually declines after layoffs.
As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
The medications still amount to around $500 per month for those without insurance—out of reach for many patients. And even ...
By Rishika Sadam HYDERABAD (Reuters) -Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly ...
Michael Douglas is following in Evangeline Lilly’s footsteps as he takes a step back from Hollywood after a decades-long ...
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Eli Lilly is grabbing investor attention thanks to sharp earnings and revenue growth projections, though its Zacks Rank ...
Eli Lilly stock currently trades below its 50-week average, offering a strong entry point despite continued dominance in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results